Bipolar Androgen-based Therapy for Prostate Cancer (BAT)

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Recurrent Prostate Cancer
Interventions
DRUG

Testosterone cypionate

DEPO-Testosterone Injection, for intramuscular injection, contains testosterone cypionate which is the oil-soluble of the androgenic hormone testosterone. Testosterone cypionate is a white or creamy white crystalline powder, odorless or nearly so and stable in air. DEPO-Testosterone Injection is available in two strengths, 100 mg/mL and 200 mg/mL testosterone cypionate.

DRUG

Goserelin

"Goserelin is a hormone therapy, for intramuscular injectionis. It is classified as an LHRH agonist."

DRUG

Leuprolide

Leuprolide is a gonadotropin-releasing hormone (GnRH) agonist. For intramuscular injection.

Trial Locations (1)

21231

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT01750398 - Bipolar Androgen-based Therapy for Prostate Cancer (BAT) | Biotech Hunter | Biotech Hunter